Abstract
Background Severely debilitating plantar keratoderma pain is the most distressing clinical feature of pachyonychia congenita (PC). Several earlier publications reported therapeutic success with botulinum toxin (Btx) plantar injections. Objectives To describe our 4‐year experience during which we administered a total of 30 plantar Btx injections to five PC patients following an optimized protocol. Methods Five patients with PC (age 21‐54 years) who were treated at our medical center from 4/2015 to 6/2018 were included in the study. After an ultrasound‐guided nerve block performed by an anesthesiologist, the patients received plantar intradermal injections of Btx A. To ascertain the effect of the treatment, we used a dedicated quality‐of‐life questionnaire for PC patients (PCQoL) and asked the patients to evaluate the intensity of eight parameters pertaining to their symptoms at baseline and before every treatment session. At study closure, patients were asked to evaluate the maximal improvement in the same eight parameters throughout the study period. Results All patients demonstrated a decrease in PCQoL scores during the follow‐up period. All patients showed a significant improvement in PCQoL after the first treatment session and at the last evaluation (P = 0.043). The best improvement scores concerned morning feet burning and long‐distance walking (> 500 m). The scores were significantly lower if the intervals between Btx injections were <100 days. Conclusions Btx treatment of PC‐associated keratoderma following an optimized protocol leads to a major change in patients’ quality of life.

This publication has 18 references indexed in Scilit: